🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase I Combination Study of CYC065 and Venetoclax for Relapsed or Refrac...
Status
Completed
Location
MD Anderson Cancer Center
Start Date
2019-08-02
Trial ID
NCT04017546
Treatments Being Tested
A Phase I Combination Study of CYC065 and Venetoclax for Relapsed or Refrac...
Status
Completed
Location
Investigational Site
Start Date
2019-01-25
Trial ID
NCT03739554
Treatments Being Tested
This is an open-label, single arm, dose escalation study in patients with a...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2015-09-28
Trial ID
NCT02552953
Treatments Being Tested
This will be a Phase 1, open-label, single dose study of the Absorption, Me...
Status
Completed
Location
Labcorp Clinical Research Unit
Start Date
2023-03-03
Trial ID
NCT05817890
Treatments Being Tested
This proof-of-concept platform trial is designed to cover the targeting of ...
Status
Recruiting
Location
Rigshospitalet
Start Date
2016-08-03
Trial ID
NCT02813135
This is a 2-part, phase 1/2, open-label, multicenter study designed to eval...
Status
Suspended
Location
City of Hope
Start Date
2021-10-22
Trial ID
NCT05168904
Treatments Being Tested
This is a 2-part, phase 1/2, open-label, multicenter study designed to eval...
Status
Unknown
Location
City of Hope
Start Date
2021-07-12
Trial ID
NCT04983810
Treatments Being Tested